High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein-Protein Interaction.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2018-02-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.7b01455PMID 29438612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation

  2017cited by this paper
• Blocking an N-terminal acetylation–dependent protein interaction inhibits an E3 ligase

  2017cited by this paper
• Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage

  2016cited by this paper
• Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation

  2015cited by this paper
• Protein neddylation: beyond cullin–RING ligases

  2014cited by this paper
• Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy

  2014cited by this paper
• Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8.

  2014cited by this paper
• Cullin-RING Ligases as attractive anti-cancer targets.

  2013cited by this paper
• Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay

  2013cited by this paper
• Principles and applications of halogen bonding in medicinal chemistry and chemical biology.

  2013cited by this paper
• Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic.

  2013cited by this paper
• N-Terminal Acetylation Acts as an Avidity Enhancer Within an Interconnected Multiprotein Complex

  2011cited by this paper
• Molecular replacement with MOLREP.

  2010cited by this paper
• Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets

  2010cited by this paper
• Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinity.

  2009cited by this paper
• An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

  2009cited by this paper
• Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP).

  2008cited by this paper
• Drug discovery in the ubiquitin–proteasome system

  2006cited by this paper
• Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas.

  2006cited by this paper
• The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle*

  2005cited by this paper
• Function and regulation of cullin–RING ubiquitin ligases

  2005cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Nedd8 on cullin: building an expressway to protein destruction

  2004cited by this paper
• Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.

  2004cited by this paper
• A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8

  2004cited by this paper
• Improved protein–ligand docking using GOLD

  2003cited by this paper
• Identification of the Activating and Conjugating Enzymes of the NEDD8 Conjugation Pathway*

  1999cited by this paper
• The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death.

  1998cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper

• DCN-type NEDD8 E3 ligases: Structure, biological function and small-molecule inhibitor.

  2026cites this paper
• Decoding neddylation in malignancies: molecular mechanisms, biological functions, therapeutic resistance, and clinical potential

  2026cites this paper
• From Mechanism to Medicine: Peptide-Based Approaches for Cancer Diagnosis and Therapy

  2025cites this paper
• The role of neddylation in colorectal cancer and its therapeutic potential

  2025cites this paper
• PTEN neddylation aggravates CDK4/6 inhibitor resistance in breast cancer

  2025cites this paper
• Neddylation: from regulatory mechanisms to clinical implications in cancer.

  2025cites this paper
• Protein neddylation and its role in health and diseases

  2024cites this paper
• Identification of novel benzothiazole derivatives as inhibitors of NEDDylation pathway to inhibit the progression of gastric cancer.

  2024cites this paper
• Research progress of LSD1-based dual-target agents for cancer therapy.

  2024cites this paper
• Deciphering the roles of neddylation modification in hepatocellular carcinoma: Molecular mechanisms and targeted therapeutics

  2024cites this paper
• Inhibiting neddylation: A new strategy for tumor therapy

  2024cites this paper
• Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy.

  2024cites this paper
• Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling.

  2024cites this paper
• A comprehensive review on DCN1 protein, inhibitors and their therapeutic applications.

  2024cites this paper
• Studies on diketopiperazine and dipeptide analogs as opioid receptor ligands.

  2023cites this paper
• Protein neddylation in lung tumorigenesis: Target validation and targeted therapy

  2023cites this paper
• Targeting cullin neddylation for cancer and fibrotic diseases

  2023influential citation
• Discovery of neddylation E2s inhibitors with therapeutic activity

  2023cites this paper
• NEDD8-conjugating enzyme E2s: critical targets for cancer therapy

  2023cites this paper
• Structure-based assessment and druggability classification of protein–protein interaction sites

  2022cites this paper
• The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer

  2022cites this paper
• Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions

  2021cites this paper
• A Destiny for Degradation: Interplay between Cullin-RING E3 Ligases and Autophagy.

  2021cites this paper
• Development of phenyltriazole thiol-based derivatives as highly potent inhibitors of DCN1-UBC12 interaction.

  2021cites this paper
• Targeting neddylation E2s: a novel therapeutic strategy in cancer

  2021influential citation
• An affinity prediction approach for the ligand of E3 ligase Cbl-b and an insight into substrate binding pattern.

  2021cites this paper
• Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2M

  2021cites this paper
• Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity

  2021cites this paper
• Neddylation Alleviates Methicillin-Resistant Staphylococcus aureus Infection by Inducing Macrophage Reactive Oxygen Species Production

  2021cites this paper
• Discovery of a cinnamyl piperidine derivative as new neddylation inhibitor for gastric cancer treatment.

  2021cites this paper
• Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment

  2021cites this paper
• Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects.

  2021cites this paper
• Targeting Protein Neddylation for Cancer Therapy.

  2020cites this paper
• Review of NEDDylation inhibition activity detection methods.

  2020cites this paper
• Investigating the binding mechanism of piperidinyl ureas inhibitors based on the UBC12-DCN1 interaction by 3D-QSAR, molecular docking and molecular dynamics simulations

  2020influential citation
• Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth invitro and invivo.

  2020cites this paper
• [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].

  2020cites this paper
• Development of Nanobodies as first-in-class inhibitors for the NEDP1 deNEDDylating enzyme

  2020cites this paper
• Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes

  2020cites this paper
• Small molecules targeting the NEDD8·NAE protein–protein interaction

  2020cites this paper
• Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.

  2020cites this paper
• Virtual screening identification of novel chemical inhibitors for aberrant interactions between pathogenic mutant SOD1 and tubulin

  2019cites this paper
• Structure-Based Discovery of SD-36 as a Potent, Selective and Efficacious PROTAC Degrader of STAT3 Protein.

  2019cites this paper
• Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth.

  2019cites this paper
• Targeting the DCN1-UBC12 protein-protein interaction: novel approaches and future directions.

  2019cites this paper
• Meeting Proceedings from ICBS 2018- Toward Translational Impact.

  2019cites this paper
• Pharmaceutical Interfering of Neddylation as Promising Treatments for Various Cancers.

  2019cites this paper
• Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein Interaction.

  2019cites this paper
• Anticancer drug discovery by targeting cullin neddylation

  2019cites this paper
• Discovery of Novel Pyrazolo-Pyridone DCN1 Inhibitors Controlling Cullin Neddylation.

  2019cites this paper
• Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.

  2019cites this paper
• Patent highlights October-November 2018.

  2019cites this paper
• Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.

  2018cites this paper
• Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.

  2018cites this paper
• Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance.

  2018cites this paper